Pancreatic polypeptide and peptide YY inhibit the denervated canine pancreas.
Pancreatic polypeptide and peptide YY are inhibitors of pancreatic exocrine secretion in vivo but not in vitro, which suggests secondarily mediated mechanism(s) of action. To determine the role of extrinsic neural and intrinsic cholinergic elements on this inhibitory effect, a total of nine dogs underwent two-stage extrapancreatic denervation and creation of a chronic pancreatic fistula. After recovery, pancreatic polypeptide or peptide YY (400 pmol/kg/h) was administered during the intermediate hour of a 3-hour secretion (125 ng/kg/h)/cholecystokinin (50 ng/kg/h) infusion. Exocrine secretion pancreatic polypeptide or peptide YY hours was compared with that of the first and third hours. The studies were then repeated during infusion of atropine (10 micrograms/kg/h). Despite extrinsic denervation, pancreatic polypeptide and peptide YY significantly inhibited secretin/cholecystokinin-induced pancreatic output. Although less profound, significant inhibition persisted in the presence of an atropine background. Pancreatic polypeptide or peptide YY infusion also decreased the exocrine response to meal stimulation. We conclude that the inhibitory effects of pancreatic polypeptide and peptide YY are not mediated by extrapancreatic, and possibly not by intrapancreatic cholinergic, neural pathways.
DeMar
A R
AR
Department of Surgery, UCLA School of Medicine.
Taylor
I L
IL
Fink
A S
AS
D000818:Animals; D002766:Cholecystokinin / Q000494:pharmacology; D003714:Denervation; D004285:Dogs; D005768:Gastrointestinal Hormones / Q000494:pharmacology*; D010179:Pancreas / Q000187:drug effects* / Q000294:innervation / Q000601:surgery; D010191:Pancreatic Polypeptide / Q000494:pharmacology*; D019894:Peptide YY; D010455:Peptides / Q000494:pharmacology*; D012633:Secretin / Q000494:pharmacology
D005768:Gastrointestinal Hormones; D010455:Peptides; D019894:Peptide YY; D012633:Secretin; D010191:Pancreatic Polypeptide; D002766:Cholecystokinin